Key result
Both Atrial-EAVM and Atrial-LGE are linked to ~2% higher post-ablation arrhythmia recurrence.
Why the study?
Atrial-LGE and Atrial-EAVM quantify anatomical and functional atrial cardiomyopathy, but the relationships between these modalities and their outcomes in patients with AF undergoing ablation required exploration.
Do Atrial-LGE and Atrial-EAVM correlate in quantifying atrial cardiomyopathy and predict arrhythmia recurrence in patients with atrial fibrillation undergoing first-time ablation?
Population
123 patients with AF undergoing first-time ablation
Comparison
Atrial-LGE vs Atrial-EAVM disease quantification
Design
Observational study
Authors
Loading...
May inform post-AF ablation recurrence risk via atrial fibrosis measures; leaves open incremental value and optimal clinical integration.
Observational (n=123)
Do Atrial-LGE and Atrial-EAVM correlate in quantifying atrial cardiomyopathy and predict arrhythmia recurrence in patients with atrial fibrillation undergoing first-time ablation?
Effect estimate: HR 1.02 (95% CI 1.01-1.04)
p-value: p=0.047
Atrial-EAVM and Atrial-LGE are moderately correlated in quantifying atrial cardiomyopathy, with agreement dependent on disease severity, and both modalities predict arrhythmia recurrence after first-time AF ablation.
Sim et al. (2024) conducted an observational in atrial fibrillation (n=123). Atrial-LGE and Atrial-EAVM was evaluated on recurrence of arrhythmia following ablation (HR 1.02, 95% CI 1.01-1.04, p=0.047). Both Atrial-EAVM and Atrial-LGE were associated with arrhythmia recurrence following ablation (Atrial-LGE HR 1.02, 95% CI 1.01-1.04; Atrial-EAVM HR 1.02, 95% CI 1.005-1.03).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: